Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]
Aditxt, Inc. (ADTX)
Company Research
Source: Canadian Business Journal
Overwhelming shareholder support in favour of take-private transaction with AditxtStudies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal models after one yearAlignment with U.S. Food and Drug Administration on development requirements for ATI-1801 NDA SubmissionHALIFAX, Nova Scotia, Nov. 14, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the second quarter of its fiscal year 2025, which ended on September 30, 2024. All figures are stated in Canadian dollars unless otherwise stated.“During fiscal year 2025, Appili shareholders voted overwhelmingly in favor of the transaction with Aditxt, facilitating our access to capital and activating promising opportunities for Appili,” said Dr. Don Cilla, President and
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 [Yahoo! Finance]Yahoo! Finance
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]Canadian Business Journal
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025GlobeNewswire
- Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time [Yahoo! Finance]Yahoo! Finance
- Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern TimeBusiness Wire
ADTX
Sec Filings
- 1/27/25 - Form DEF
- 1/17/25 - Form PRER14A
- 1/13/25 - Form 8-K
- ADTX's page on the SEC website